Szymczak, M.; Heidecke, H.; Żabińska, M.; Janek, Ł.; Wronowicz, J.; Kujawa, K.; Bukowiec-Marek, K.; Gołębiowski, T.; Skalec, K.; Schulze-Forster, K.;
et al. The Influence of Anti-ETAR and Anti-CXCR3 Antibody Levels on the Course of Specific Glomerulonephritis Types. J. Clin. Med. 2024, 13, 7752.
https://doi.org/10.3390/jcm13247752
AMA Style
Szymczak M, Heidecke H, Żabińska M, Janek Ł, Wronowicz J, Kujawa K, Bukowiec-Marek K, Gołębiowski T, Skalec K, Schulze-Forster K,
et al. The Influence of Anti-ETAR and Anti-CXCR3 Antibody Levels on the Course of Specific Glomerulonephritis Types. Journal of Clinical Medicine. 2024; 13(24):7752.
https://doi.org/10.3390/jcm13247752
Chicago/Turabian Style
Szymczak, Maciej, Harald Heidecke, Marcelina Żabińska, Łucja Janek, Jakub Wronowicz, Krzysztof Kujawa, Karolina Bukowiec-Marek, Tomasz Gołębiowski, Karolina Skalec, Kai Schulze-Forster,
and et al. 2024. "The Influence of Anti-ETAR and Anti-CXCR3 Antibody Levels on the Course of Specific Glomerulonephritis Types" Journal of Clinical Medicine 13, no. 24: 7752.
https://doi.org/10.3390/jcm13247752
APA Style
Szymczak, M., Heidecke, H., Żabińska, M., Janek, Ł., Wronowicz, J., Kujawa, K., Bukowiec-Marek, K., Gołębiowski, T., Skalec, K., Schulze-Forster, K., Konieczny, A., & Banasik, M.
(2024). The Influence of Anti-ETAR and Anti-CXCR3 Antibody Levels on the Course of Specific Glomerulonephritis Types. Journal of Clinical Medicine, 13(24), 7752.
https://doi.org/10.3390/jcm13247752
